<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35688953</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>10</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>MIF homolog d-dopachrome tautomerase (D-DT/MIF-2) does not inhibit accumulation and toxicity of misfolded SOD1.</ArticleTitle><Pagination><StartPage>9570</StartPage><MedlinePgn>9570</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9570</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-13744-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by loss of upper and lower motor neurons. About 20% of familial ALS cases are caused by dominant mutations in SOD1. It has been suggested that toxicity of mutant SOD1 results from its misfolding, however, it is unclear why misfolded SOD1 accumulates within specific tissues. We have demonstrated that macrophage migration inhibitory factor (MIF), a multifunctional protein with cytokine/chemokine and chaperone-like activity, inhibits the accumulation and aggregation of misfolded SOD1. Although MIF homolog, D-dopachrome tautomerase (D-DT/MIF-2), shares structural and genetic similarities with MIF, its biological function is not well understood. In the current study, we investigated, for the first time, the mechanism of action of D-DT in a model of ALS. We show that D-DT inhibits mutant SOD1 amyloid aggregation in vitro, promoting the formation of amorphous aggregates. Moreover, we report that D-DT interacts with mutant SOD1, but does not inhibit misfolded mutant SOD1 accumulation and toxicity in neuronal cells. Finally, we show that D-DT is expressed mainly in liver and kidney, with extremely low expression in brain and spinal cord of adult mice. Our findings contribute to better understanding of D-DT versus MIF function in the context of ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Alaskarov</LastName><ForeName>Amina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O.B. 653, 84105, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Barel</LastName><ForeName>Shir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O.B. 653, 84105, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakavayev</LastName><ForeName>Shamchal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O.B. 653, 84105, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Joy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O.B. 653, 84105, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Israelson</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Faculty of Health Sciences and The Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, P.O.B. 653, 84105, Beer Sheva, Israel. adriani@bgu.ac.il.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008263">Macrophage Migration-Inhibitory Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.3.-</RegistryNumber><NameOfSubstance UI="D019746">Intramolecular Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.3.3.12</RegistryNumber><NameOfSubstance UI="C042501">dopachrome isomerase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019746" MajorTopicYN="N">Intramolecular Oxidoreductases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008263" MajorTopicYN="Y">Macrophage Migration-Inhibitory Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>10</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35688953</ArticleId><ArticleId IdType="pmc">PMC9187739</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-13744-7</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-13744-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, et al. Prognostic factors in ALS: A critical review. Amyotroph. Lateral Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov, D., Mansfield, C., Moussy, A. &amp; Hermine, O. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front. Aging Neurosci.9, 68, doi:10.3389/fnagi.2017.00068 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada H. Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Exp. Opin. Pharmacother. 2017;18:735&#x2013;738. doi: 10.1080/14656566.2017.1319937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2017.1319937</ArticleId><ArticleId IdType="pubmed">28406335</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Sayana P, Zhang X, Le W. Genetics of amyotrophic lateral sclerosis: an update. Mol. Neurodegen. 2013;8:28. doi: 10.1186/1750-1326-8-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsultan AA, Waller R, Heath PR, Kirby J. The genetics of amyotrophic lateral sclerosis: Current insights. Degen. Neurol. Neuromuscul. Dis. 2016;6:49&#x2013;64. doi: 10.2147/DNND.S84956.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DNND.S84956</ArticleId><ArticleId IdType="pmc">PMC6053097</ArticleId><ArticleId IdType="pubmed">30050368</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Grima JC, Rothstein JD, Lloyd TE. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD. Nucleus. 2016;7:132&#x2013;137. doi: 10.1080/19491034.2016.1172152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19491034.2016.1172152</ArticleId><ArticleId IdType="pmc">PMC4916865</ArticleId><ArticleId IdType="pubmed">27116041</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J, et al. NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res. 2018;30:150&#x2013;162. doi: 10.1016/j.scr.2018.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.06.005</ArticleId><ArticleId IdType="pubmed">29929116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016;7:10465. doi: 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, et al. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 2002;277:47551&#x2013;47556. doi: 10.1074/jbc.M207356200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207356200</ArticleId><ArticleId IdType="pubmed">12356748</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, et al. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip T, et al. Confirmation of the assignment of the human SODS gene to chromosome 21q22. Cytogenet. Cell Genet. 1978;22:521&#x2013;523. doi: 10.1159/000131014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000131014</ArticleId><ArticleId IdType="pubmed">752535</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y, Homma K, Ichijo H. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv. Biol. Regul. 2016;60:95&#x2013;104. doi: 10.1016/j.jbior.2015.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2015.10.006</ArticleId><ArticleId IdType="pubmed">26563614</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler RL, Dokholyan NV. The complex molecular biology of amyotrophic lateral sclerosis (ALS) Prog. Mol. Biol. Trans. Sci. 2012;107:215&#x2013;262. doi: 10.1016/B978-0-12-385883-2.00002-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-385883-2.00002-3</ArticleId><ArticleId IdType="pmc">PMC3605887</ArticleId><ArticleId IdType="pubmed">22482452</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai J, Lin H, Canete-Soler R, Schlaepfer WW. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS. Hum. Mol. Genet. 2005;14:2629&#x2013;2640. doi: 10.1093/hmg/ddi297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddi297</ArticleId><ArticleId IdType="pubmed">16079151</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A, et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron. 2010;67:575&#x2013;587. doi: 10.1016/j.neuron.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Agbas A, et al. Activation of brain calcineurin (Cn) by Cu-Zn superoxide dismutase (SOD1) depends on direct SOD1-Cn protein interactions occurring in vitro and in vivo. Biochem. J. 2007;405:51&#x2013;59. doi: 10.1042/BJ20061202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20061202</ArticleId><ArticleId IdType="pmc">PMC1925239</ArticleId><ArticleId IdType="pubmed">17324120</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Hamad S, Kahn J, Leyton-Jaimes MF, Rosenblatt J, Israelson A. Misfolded SOD1 accumulation and mitochondrial association contribute to the selective vulnerability of motor neurons in familial ALS: Correlation to human disease. ACS Chem. Neurosci. 2017;8:2225&#x2013;2234. doi: 10.1021/acschemneuro.7b00140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.7b00140</ArticleId><ArticleId IdType="pubmed">28715630</ArticleId></ArticleIdList></Reference><Reference><Citation>Shteinfer-Kuzmine A, et al. A VDAC1-derived N-terminal peptide inhibits mutant SOD1-VDAC1 interactions and toxicity in the SOD1 model of ALS. Front. Cell Neurosci. 2019;13:346. doi: 10.3389/fncel.2019.00346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00346</ArticleId><ArticleId IdType="pmc">PMC6702328</ArticleId><ArticleId IdType="pubmed">31474832</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, et al. ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc. Natl. Acad. Sci. USA. 2010;107:21146&#x2013;21151. doi: 10.1073/pnas.1014862107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1014862107</ArticleId><ArticleId IdType="pmc">PMC3000256</ArticleId><ArticleId IdType="pubmed">21078990</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitoh H, et al. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 2008;22:1451&#x2013;1464. doi: 10.1101/gad.1640108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1640108</ArticleId><ArticleId IdType="pmc">PMC2418582</ArticleId><ArticleId IdType="pubmed">18519638</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 2010;13:1396&#x2013;1403. doi: 10.1038/nn.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Guareschi S, et al. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc. Natl. Acad. Sci. USA. 2012;109:5074&#x2013;5079. doi: 10.1073/pnas.1115402109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115402109</ArticleId><ArticleId IdType="pmc">PMC3324021</ArticleId><ArticleId IdType="pubmed">22416121</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, Rouleau GA. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis? Ann. Neurol. 2007;62:553&#x2013;559. doi: 10.1002/ana.21319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21319</ArticleId><ArticleId IdType="pubmed">18074357</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Andersen PM, Marklund SL, Brannstrom T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2011;121:623&#x2013;634. doi: 10.1007/s00401-011-0805-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0805-3</ArticleId><ArticleId IdType="pmc">PMC3085063</ArticleId><ArticleId IdType="pubmed">21287393</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, et al. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS ONE. 2010;5:e11552. doi: 10.1371/journal.pone.0011552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011552</ArticleId><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterstrom P, Andersen PM, Brannstrom T, Marklund SL. Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients. J. Neurochem. 2011;117:91&#x2013;99. doi: 10.1111/j.1471-4159.2011.07177.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07177.x</ArticleId><ArticleId IdType="pubmed">21226712</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Cashman NR. Prion-like activity of Cu/Zn superoxide dismutase: implications for amyotrophic lateral sclerosis. Prion. 2014;8:33&#x2013;41. doi: 10.4161/pri.27602.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.27602</ArticleId><ArticleId IdType="pmc">PMC7030911</ArticleId><ArticleId IdType="pubmed">24394345</ArticleId></ArticleIdList></Reference><Reference><Citation>Pare B, et al. Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci. Rep. 2018;8:14223. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Durazo A, Whitelegge JP, Borchelt DR. An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Hum. Mol. Genet. 2010;19:4774&#x2013;4789. doi: 10.1093/hmg/ddq408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq408</ArticleId><ArticleId IdType="pmc">PMC2989888</ArticleId><ArticleId IdType="pubmed">20871097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, et al. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol. 2014;128:791&#x2013;803. doi: 10.1007/s00401-014-1342-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1342-7</ArticleId><ArticleId IdType="pubmed">25262000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerman A, et al. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathol. 2010;119:335&#x2013;344. doi: 10.1007/s00401-010-0646-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0646-5</ArticleId><ArticleId IdType="pubmed">20111867</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu HN, et al. Lack of evidence of monomer/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 2009;66:75&#x2013;80. doi: 10.1002/ana.21704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21704</ArticleId><ArticleId IdType="pubmed">19670443</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S, et al. Misfolded SOD1 is not a primary component of sporadic ALS. Acta Neuropathol. 2017;134:97&#x2013;111. doi: 10.1007/s00401-017-1688-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1688-8</ArticleId><ArticleId IdType="pmc">PMC5472502</ArticleId><ArticleId IdType="pubmed">28247063</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S, et al. Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1. Hum. Mol. Genet. 2013;22:3947&#x2013;3959. doi: 10.1093/hmg/ddt249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt249</ArticleId><ArticleId IdType="pmc">PMC5052069</ArticleId><ArticleId IdType="pubmed">23736301</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterstrom P, Graffmo KS, Andersen PM, Brannstrom T, Marklund SL. Composition of soluble misfolded superoxide dismutase-1 in murine models of amyotrophic lateral sclerosis. Neuromol. Med. 2013;15:147&#x2013;158. doi: 10.1007/s12017-012-8204-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-012-8204-z</ArticleId><ArticleId IdType="pubmed">23076707</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyton-Jaimes MF, Kahn J, Israelson A. Macrophage migration inhibitory factor: A multifaceted cytokine implicated in multiple neurological diseases. Exp. Neurol. 2018;301:83&#x2013;91. doi: 10.1016/j.expneurol.2017.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.06.021</ArticleId><ArticleId IdType="pubmed">28679106</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A, et al. Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1. Neuron. 2015;86:218&#x2013;232. doi: 10.1016/j.neuron.2015.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.02.034</ArticleId><ArticleId IdType="pmc">PMC4393372</ArticleId><ArticleId IdType="pubmed">25801706</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyton-Jaimes MF, et al. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS. Proc. Natl. Acad Sci. USA. 2016;113:10198&#x2013;10203. doi: 10.1073/pnas.1604600113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1604600113</ArticleId><ArticleId IdType="pmc">PMC5018779</ArticleId><ArticleId IdType="pubmed">27551074</ArticleId></ArticleIdList></Reference><Reference><Citation>Shvil N, et al. MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS. Cell Death Dis. 2018;9:107. doi: 10.1038/s41419-017-0130-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0130-4</ArticleId><ArticleId IdType="pmc">PMC5833700</ArticleId><ArticleId IdType="pubmed">29371591</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyton-Jaimes MF, Kahn J, Israelson A. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS. Proc. Natl. Acad Sci. USA. 2019;116:14755&#x2013;14760. doi: 10.1073/pnas.1904665116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1904665116</ArticleId><ArticleId IdType="pmc">PMC6642395</ArticleId><ArticleId IdType="pubmed">31262807</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, et al. Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene. 2004;23:4146&#x2013;4154. doi: 10.1038/sj.onc.1207490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1207490</ArticleId><ArticleId IdType="pubmed">15064733</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, et al. MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma. Blood. 2020;136:2557&#x2013;2573. doi: 10.1182/blood.2020005795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020005795</ArticleId><ArticleId IdType="pmc">PMC7714094</ArticleId><ArticleId IdType="pubmed">32582913</ArticleId></ArticleIdList></Reference><Reference><Citation>Merk M, Mitchell RA, Endres S, Bucala R. D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family. Cytokine. 2012;59:10&#x2013;17. doi: 10.1016/j.cyto.2012.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2012.03.014</ArticleId><ArticleId IdType="pmc">PMC3367028</ArticleId><ArticleId IdType="pubmed">22507380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriyama T, Fujinaga M, Koda T, Nishihira J. Cloning of the mouse gene for D-dopachrome tautomerase. Biochim Biophys. Acta. 1998;1388:506&#x2013;512. doi: 10.1016/s0167-4838(98)00214-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0167-4838(98)00214-3</ArticleId><ArticleId IdType="pubmed">9858785</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira J, et al. Molecular cloning of human D-dopachrome tautomerase cDNA: N-terminal proline is essential for enzyme activation. Biochem. Biophys. Res. Commun. 1998;243:538&#x2013;544. doi: 10.1006/bbrc.1998.8123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1998.8123</ArticleId><ArticleId IdType="pubmed">9480844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, et al. Cloning and sequencing of a cDNA encoding rat D-dopachrome tautomerase. FEBS Lett. 1995;373:203&#x2013;206. doi: 10.1016/0014-5793(95)01041-c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(95)01041-c</ArticleId><ArticleId IdType="pubmed">7589466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjork P, et al. A new enzyme activity in human blood cells and isolation of the responsible protein (D-dopachrome tautomerase) from erythrocytes. Eur. J. Haematol. 1996;57:254&#x2013;256. doi: 10.1111/j.1600-0609.1996.tb01372.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0609.1996.tb01372.x</ArticleId><ArticleId IdType="pubmed">8898931</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosengren E, et al. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol. Med. 1996;2:143&#x2013;149. doi: 10.1007/BF03402210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03402210</ArticleId><ArticleId IdType="pmc">PMC2230029</ArticleId><ArticleId IdType="pubmed">8900542</ArticleId></ArticleIdList></Reference><Reference><Citation>Merk M, et al. The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF) Proc. Natl. Acad Sci. USA. 2011;108:E577&#x2013;585. doi: 10.1073/pnas.1102941108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102941108</ArticleId><ArticleId IdType="pmc">PMC3161582</ArticleId><ArticleId IdType="pubmed">21817065</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, Kaneko K, Yamanaka K, O'Halloran TV, Nukina N. Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J. Biol. Chem. 2008;283:24167&#x2013;24176. doi: 10.1074/jbc.M802083200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M802083200</ArticleId><ArticleId IdType="pmc">PMC3259764</ArticleId><ArticleId IdType="pubmed">18552350</ArticleId></ArticleIdList></Reference><Reference><Citation>LeVine H., 3rd Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999;309:274&#x2013;284. doi: 10.1016/s0076-6879(99)09020-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0076-6879(99)09020-5</ArticleId><ArticleId IdType="pubmed">10507030</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama S, et al. Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70. Biochem. Biophys. Res. Commun. 2006;343:719&#x2013;730. doi: 10.1016/j.bbrc.2006.02.170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.02.170</ArticleId><ArticleId IdType="pubmed">16563356</ArticleId></ArticleIdList></Reference><Reference><Citation>Esumi N, et al. Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIF. Mamm Genome. 1998;9:753&#x2013;757. doi: 10.1007/s003359900858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s003359900858</ArticleId><ArticleId IdType="pubmed">9716662</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankauskas SS, Wong DWL, Bucala R, Djudjaj S, Boor P. Evolving complexity of MIF signaling. Cell Signal. 2019;57:76&#x2013;88. doi: 10.1016/j.cellsig.2019.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2019.01.006</ArticleId><ArticleId IdType="pubmed">30682543</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunther S, et al. Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets. Drug Discov. Today. 2019;24:428&#x2013;439. doi: 10.1016/j.drudis.2018.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2018.11.003</ArticleId><ArticleId IdType="pubmed">30439447</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinitski D, et al. Macrophage migration inhibitory factor (MIF)-Based therapeutic concepts in atherosclerosis and inflammation. Thromb. Haemost. 2019;119:553&#x2013;566. doi: 10.1055/s-0039-1677803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1677803</ArticleId><ArticleId IdType="pubmed">30716779</ArticleId></ArticleIdList></Reference><Reference><Citation>Presti M, et al. Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma. Oncol. Lett. 2018;16:2881&#x2013;2886. doi: 10.3892/ol.2018.8990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2018.8990</ArticleId><ArticleId IdType="pmc">PMC6096183</ArticleId><ArticleId IdType="pubmed">30127875</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli, E. et al. Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? Molecules25, doi:10.3390/molecules25051194 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179464</ArticleId><ArticleId IdType="pubmed">32155795</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli, E. et al. Overexpression of macrophage migration inhibitory factor and its homologue D-dopachrome tautomerase as negative prognostic factor in neuroblastoma. Brain Sci9, doi:10.3390/brainsci9100284 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6826588</ArticleId><ArticleId IdType="pubmed">31635049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida M, et al. Structural basis of Cu, Zn-superoxide dismutase amyloid fibril formation involves interaction of multiple peptide core regions. J. Biochem. 2016;159:247&#x2013;260. doi: 10.1093/jb/mvv091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvv091</ArticleId><ArticleId IdType="pmc">PMC4948195</ArticleId><ArticleId IdType="pubmed">26319711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanova MI, et al. Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS. Proc. Natl. Acad Sci. USA. 2014;111:197&#x2013;201. doi: 10.1073/pnas.1320786110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320786110</ArticleId><ArticleId IdType="pmc">PMC3890817</ArticleId><ArticleId IdType="pubmed">24344300</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal SS, Cristovao JS, Biesemeier A, Cardoso I, Gomes CM. Aberrant zinc binding to immature conformers of metal-free copper-zinc superoxide dismutase triggers amorphous aggregation. Metallomics. 2015;7:333&#x2013;346. doi: 10.1039/c4mt00278d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4mt00278d</ArticleId><ArticleId IdType="pubmed">25554447</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, et al. Out-of-register beta-sheets suggest a pathway to toxic amyloid aggregates. Proc. Natl. Acad Sci. USA. 2012;109:20913&#x2013;20918. doi: 10.1073/pnas.1218792109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1218792109</ArticleId><ArticleId IdType="pmc">PMC3529048</ArticleId><ArticleId IdType="pubmed">23213214</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat. Neurosci. 2016;19:668&#x2013;677. doi: 10.1038/nn.4272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4272</ArticleId><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia NK, et al. Curcumin binds to the pre-fibrillar aggregates of Cu/Zn superoxide dismutase (SOD1) and alters its amyloidogenic pathway resulting in reduced cytotoxicity. Biochim. Biophys. Acta. 1854;426&#x2013;436:2015. doi: 10.1016/j.bbapap.2015.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2015.01.014</ArticleId><ArticleId IdType="pubmed">25666897</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouertatani-Sakouhi H, et al. Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action. J. Biol. Chem. 2010;285:26581&#x2013;26598. doi: 10.1074/jbc.M110.113951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.113951</ArticleId><ArticleId IdType="pmc">PMC2924096</ArticleId><ArticleId IdType="pubmed">20516071</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan C, et al. MIF intersubunit disulfide mutant antagonist supports activation of CD74 by endogenous MIF trimer at physiologic concentrations. Proc. Natl. Acad. Sci. U S A. 2013;110:10994&#x2013;10999. doi: 10.1073/pnas.1221817110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1221817110</ArticleId><ArticleId IdType="pmc">PMC3703972</ArticleId><ArticleId IdType="pubmed">23776208</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto, H. et al. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution. Biochemistry38, 3268&#x2013;3279, doi:10.1021/bi982184o (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10079069</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy12, 1&#x2013;222, doi:10.1080/15548627.2015.1100356 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835977</ArticleId><ArticleId IdType="pubmed">26799652</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakavayev S, et al. Cu/Zn-superoxide dismutase and wild-type like fALS SOD1 mutants produce cytotoxic quantities of H2O2 via cysteine-dependent redox short-circuit. Sci. Rep. 2019;9:10826. doi: 10.1038/s41598-019-47326-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-47326-x</ArticleId><ArticleId IdType="pmc">PMC6658568</ArticleId><ArticleId IdType="pubmed">31346243</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee V, et al. Superoxide dismutase 1 (SOD1)-derived peptide inhibits amyloid aggregation of familial amyotrophic lateral sclerosis SOD1 mutants. ACS Chem. Neurosci. 2016;7:1595&#x2013;1606. doi: 10.1021/acschemneuro.6b00227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.6b00227</ArticleId><ArticleId IdType="pubmed">27540759</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman AM, et al. Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog D-dopachrome tautomerase. J. Immunol. 2008;181:2330&#x2013;2337. doi: 10.4049/jimmunol.181.4.2330.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.4.2330</ArticleId><ArticleId IdType="pmc">PMC2709419</ArticleId><ArticleId IdType="pubmed">18684922</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>